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Women, Children and Drug Use 
Eimear Farrell
4.1 Introduction
This paper provides an overview of the issues relevant to women and children
affected by drug misuse in Ireland. It attempts to bring together very disparate
sources of information in order to gain an understanding of the main issues
facing women drug users and their children.  The main areas covered are:
4.2 Historical and Cultural Background 
4.3 Epidemiology of Female Drug Use 
4.4 HIV/AIDS, Women, Children and Drug Use
4.5 Drug Use among Female Prisoners
4.6 Pregnancy and Drug Use
4.7 Children and Drug Use
4.8 Demand Reduction (Prevention, Treatment and Care) and Female 
Drug Users 
4.9 Barriers to Service Access
4.10 Conclusion
4.11 References
One of the most striking features of the available Irish research is the emphasis
on pregnancy and drug use, and the scarcity of studies focusing on children of
drug users. 
1 This chapter was written in 1999 as a 'Key Issues' chapter for inclusion in Moran, R., O'Brien, M., Farrell,
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E. & Dillon, L. (1999). National Report on Drug Issues Ireland 1999.  Internal document. Dublin: Drug
Misuse Research Division, The Health Research Board. Only National Drug Treatment Reporting System
figures have been updated in the current chapter.
4.2  Historical and Cultural Background
According to the United Nations Drug Control programme (UNDCP), female
involvement in drug use may be divided into three categories:
1. female non-drug users with drug-abusing families or partners;
2. females who consume drugs illicitly; and
3. females who are involved in the production and/or distribution of 
drugs.
In Ireland, very little is known about both non-drug-using women who have a
drug-using partner or family, and women who are involved in the production
and/or distribution of drugs.  
No estimate is available of the number of women affected by familial drug use.
However, a number of support groups have been set up for parents and partners
of drug users.  These support groups include the Coolmine Family Association
and a group established for parents of drug users, entitled 'Le Chéile' (Together),
which was established in 1993 but has since been discontinued. 
The only Irish data available on women and drug production and distribution
are police statistics on drug offences.  These statistics indicate that between 1990
and 1994, approximately 14 per cent of people charged with drug offences were
female (An Garda Síochána, 1991, 1992, 1993, 1994). In the following two years
(1995 and 1996), this figure decreased, with about 10 per cent of drug-related
offences being committed by women  (An Garda Síochána, 1995, 1996). In 1997
this figure almost doubled, increasing to 22 per cent (An Garda Síochána, 1997).
There is some anecdotal evidence that women in general, and pregnant women
in particular, are increasingly being used in drug trafficking, which may explain
the sudden increase in the percentage of women being charged with drug-
related offences in 1997.
Although more information is available on women drug users in Ireland relative
to the other two categories, it is not possible to examine long-term trends, as the
collection of epidemiological data on drug use is a relatively recent
phenomenon. 
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4.3  Epidemiology of Female Drug Use
An important issue when considering women and drug use is the extent to
which male and female drug users differ in terms of drug-using history, patterns
of risk behaviour and health issues.
The main source of information on gender differences and drug use in Ireland is
the National Drug Treatment Reporting System (NDTRS), which provides
statistics on treated drug misuse. An analysis of the NDTRS data for 1998
indicates that almost a third (30%) of drug users presenting for treatment were
female.  Male and female clients were similar in age, the mean age of female
clients being 24 and the mean age of male clients being 25 (NDTRS)2. As with the
general population, women seeking treatment were more likely to be classified
as lone parents (9%) than were men (0.3%).  Women were also more likely to be
living with a drug-using partner: 36 per cent of women lived with a drug user
compared to 22 per cent of men. This finding may relate to the fact that women
are generally more likely to be introduced to drugs by a male partner (Ettore,
1992).  The majority of both male (70%) and female drug users (75%) seeking
treatment were unemployed. Interestingly, more women (88%) than men (78%)
reported that opiates were their primary drug of misuse.  However, a lower
proportion of male (35%) than female (39%) users reported that they were
currently injecting.  In terms of risk behaviour, of those who were currently
injecting, women (28%) were slightly more likely to be sharing injecting
equipment than were men (25%).
Gender differences in drug usage, risk behaviour and health have also been
studied among drug users attending an inner-city Dublin needle exchange
programme (Cox, O'Shea & Geoghegan, submitted for publication).  Over a year
and a half, 934 consecutive new attendees at the needle exchange were
interviewed. The study found that female clients were significantly younger
than male clients and were more likely to inject their primary drug daily.
Women were also more likely to suffer from injecting-related problems such as
difficulty finding injecting sites.  Men were less likely to have a partner who was
injecting and less likely to be living with an injecting drug user. In terms of risk
behaviour, women were more likely to share injecting equipment with their
sexual partner and to report recent sharing of injecting paraphernalia.  However,
women had a shorter interval between injecting and attending a needle
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exchange than did men. In terms of health and general well being, women were
more likely to
2 National Drug Treatment Reporting System.
report weight loss and abscesses and were less likely to have had a hepatitis B
vaccination than men. Women were also more likely to report mental health
problems such as depression, suicidal tendencies, isolation and anxiety.
However, women were more likely to have visited a general practitioner in the
last three months and to have a medical card.  Thus, the findings suggest that
women were more likely than their male counterparts to engage in risk
behaviour, but were more likely to acknowledge these difficulties and to seek
help. 
Summary
Consistent with the European situation, about a quarter of drug users who
present for treatment in Ireland are female (EMCDDA, 1998). Although fewer
women than men are captured in the treatment figures, research suggests that
women in Ireland are more likely to suffer negative consequences from drug use
than men.  It also suggests that women in Ireland are more likely than men to
engage in risk behaviour, to be living with a drug-using partner and to suffer
from drug-related health problems.
4.4   HIV/AIDS, Women, Children and Drug Use 2
Drug use can have serious health-related consequences, particularly in relation
to HIV and hepatitis B and hepatitis C.  While no national information is
available on hepatitis B and C, statistics on the incidence of HIV in the
population are routinely published by the Department of Health and Children.
These statistics contain information on the percentage of HIV-positive cases that
are related to intravenous drug use (IDU).
As Table 4.1 indicates, from January 1986 to December 1998, 42 per cent of all
those who tested positive for HIV (n=1,986) were IDUs. Of these, almost a
quarter (24%) were female.  During the same period, a total of 149 children were
deemed 'at risk' of becoming HIV positive, representing 7.5 per cent of all HIV-
positive cases. The HIV statistics for children do not indicate the route of
infection and, therefore, it is not known to what extent HIV among children is
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attributable to maternal drug use or other sources, e.g. transfusions or
heterosexual or sexual transmission. 
2 See Chapter 2 for a discussion of the HIV/AIDS figures up to the end of 1999. 
The available statistics for AIDS present a similar picture.  Two-fifths (41%) of
the 650 AIDS cases diagnosed between January 1986 and 31 December 1998 were
IDU related, of which, again, a quarter were female (see Table 4.2).  An age
breakdown is also available for AIDS cases, which indicates that twenty-six
cases of AIDS (representing 4% of all AIDS cases) occurred among children
under the age of 15.  Unlike the HIV figures, the AIDS figures for children
provide information on the route of infection.  These figures indicate that from
1982 to 1998, thirteen children born to IDUs developed AIDS, representing 2 per
cent of all AIDS cases over this time period.  
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TABLE 4.1
T tal Number of Known HIV Cases in Ireland: IDU Related, by Gender;
and Children at Risk.  Numbers and Percentages.
Cumulative figures January 1986 - December 1998.
Total HIV
Cases IDU Cases Female IDUs Male IDUs
Children
at Risk
1,986 844  (42%) 202  (23.93%) 628* 149  (7.5%)
Source: Department of Health and Children.
* In 14 of the 844 IDU-related cases of HIV, the gender was not known.
650 266 (41%) 200 (75.2%) 66 (24.8%) 26 (4%) 13 (2%)
TABLE 4.2
Total Number of AIDS Cases in Ireland: IDU-Related, by Gender;
among Children < 15; and among Children born to IDUs.
Numbers and Percentages. Cumulative Figures January 1986 - December 1998.
Source: Department of Health and Children.
IDU-Related AIDS Cases
Gender Breakdown
Male
Total
Female
Total
AIDS
Cases
AIDS
Cases
among
Children
Aged < 15
AIDS
Cases
among
Children
born to IDUs
332 148 (44.6%) 109 (73.6%) 39 (26.4%) 11 (3.3%) 8 (2.4%)
IDU-Related AIDS Deaths
Gender Breakdown
Male
Total
Female
Total
AIDS
Deaths
AIDS-Related
Deaths
among
Children
Aged < 15
AIDS-Related
Deaths
among
Children
born to IDUs
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TABLE 4.3
Total Number of AIDS Related Deaths in Ireland: IDU-Related, and Gender;
among Children < 15; and among Children born to IDUs.
Numbers and Percentages. Cumulative Figures January 1986 - December 1998.
Source: Department of Health and Children.
Figures are also available for AIDS-related deaths (see Table 4.3). These figures
indicate that between 1982 and 1998, 44.6 per cent of AIDS-related deaths were
IDU related, and of these, 26.4 per cent were female. An age breakdown of
known AIDS deaths shows that eleven (3.3%) occurred among children under
the age of 15.  The figures also reveal that eight children (representing 2.4% of all
AIDS-related deaths) born to IDUs are reported to have died from AIDS. 
It is also possible to identify trends in known cases of IDU-related HIV among
women and known cases of HIV among children (see Table 4.4). An analysis of
these figures over a three-year period (1996-1998) indicates that the proportion
of IDU-related cases of HIV among females more than doubled in 1998,
compared with 1997 and 1996.   Similarly, the number of new cases among
children doubled between 1997 and 1998.  This may be a reflection of increased
testing for HIV among pregnant women. Routine antenatal testing for HIV was
introduced in 1999, in order to allow a mother infected with HIV to receive
special treatment that could reduce the likelihood of her baby becoming infected
by up to 66 per cent (Department of Health and Children, 1999b).  The testing
was introduced following a five-year study (1992-1997), which estimated the
incidence of HIV among new-borns, using unlinked, anonymous antenatal HIV
screening.  The screening was carried out on blood specimens routinely collected
for rubella serology from pregnant women attending antenatal clinics.  A total of
287,099 tests were carried out over the five years, of which 64 were positive for
HIV, giving an incidence rate of 0.02 per cent.  However, the extent to which
HIV-positive results were drug related is unknown.
A study of HIV infection among women attending thirteen genitourinary
medicine/HIV clinics in England, and one clinic in both Dublin and Edinburgh,
found that women in Dublin and Edinburgh were more likely to have contracted
the disease through IDU rather than sexual intercourse (MRC Study Group,
1996).  For over two-thirds of the seventy-three women interviewed in Dublin
and for four-fifths of the forty-two women interviewed in Edinburgh, the most
probable route of transmission was drug use; whereas in London (n=266) and in
the rest of England (n=19), only one-fifth (21%) of women were thought to have
been infected through drug use. Although not directly comparable, an analysis
of Irish statistics on the route of infection among women with AIDS (collected by
the Department of Health and Children) indicates that, across all cases, a smaller
percentage of women contracted AIDS as a result of drug use than is suggested
by the MRC study. The Department of Health and Children statistics indicate
that 54 per cent of registered female AIDS cases were IDU related (Department
of Health and Children, 1999a).
Although basic epidemiological data are available for the incidence of HIV, very
little is known about the needs of female drug users with HIV.  However, one
Dublin study has investigated the needs of HIV-positive women by consulting
with HIV-positive women and healthcare workers involved in their care (Butler
& Woods, 1992).  The results indicate that Dublin women who were HIV-
positive were primarily concerned with taking care of their families and saw
their own health problems as being of secondary importance. The healthcare
workers interviewed stated that HIV-positive women in Dublin tended to be
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TABLE 4.4
Ireland 1996 - 1998. Numbe  of IDU-Related HIV Cases among Women,
and Number of New Childhood Cases. Numbers and Percentages.
1996 1997 1998
Women Children Women Children Women Children
3 (15%)* 8 3 (14%)* 10 10 (38.4%)* 20
Source: Department of Health and Children.
* Percentages are calculated based on the total number of new, IDU-related HIV cases.
young, working-class and to have contracted HIV through IDU and/or sexual
relationships with drug-using men. When asked about the services available to
HIV-positive women, respondents acknowledged that, while a broad range of
services was available, many of these were poorly co-ordinated.  They also felt
that there was a lack of practical support for those who were ill and that the drug
services could not yet be described as 'user friendly'.  It was also suggested that
HIV-positive women did not take up health and social services to the same
extent as men for two reasons.  Firstly, women were often too busy with child-
minding and other chores to avail of services and, secondly, they feared being
labelled as 'unfit' mothers.  However, since this study was conducted, there has
been a major expansion of drugs services.
Summary
The proportion of female IDU-related HIV and AIDS cases is similar to the ratio
of male to female drug users in treatment.  Approximately one-quarter of IDU-
related AIDS and HIV cases occur among women.  The number of IDU-related
HIV cases appears to have increased in recent years.  Very little information is
available about the needs of female IDUs with HIV/AIDS.  One study suggests
that HIV-positive drug-using women with children may be inhibited from
seeking treatment owing to concerns about being seen as an 'unfit mother'
(Butler & Woods, 1992).
4.5  Drug Use among Female Prisoners
Drug use among women in prison has received some attention in Ireland. A
study of 100 consecutive women prisoners entering the main prison in Dublin
suggests that drug misuse is a significant problem among the female prison
population. The study, conducted over a six-week period in February and March
1994, found that sixty of the women interviewed had used drugs (Carmody &
McEvoy, 1996).   Among the sixty women who used drugs, heroin was the most
frequently-used drug (95%), followed by methadone (83%) and benzodiazepines
(83%).  Cocaine had been used by almost two-thirds (63%) of the women, and
amphetamines by over a third (35%).  All except one of the sixty women were
using drugs on imprisonment, as indicated by a positive urine test for opiates.
The vast majority of the drug-using women (92%) were daily users, and 86 per
cent stated that injecting was the primary route of administration. Almost half of
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those who had injected had shared a needle in the last month. Interestingly, 43
per cent of the women described methadone as one of their drugs of first choice.
When asked about their history of drug treatment, four-fifths of the drug-using
women stated they had been detoxified at least once, and over half (57.1%) had
been detoxified three or more times.  Over half (53%) had been detoxified in
prison. About half the drug-using women had been on methadone maintenance
at some stage in the past, and 43.3 per cent were on methadone maintenance at
the time of imprisonment. The results of the study also indicate a possible link
between drug use and psychiatric problems among this population, as 61 per
cent of the forty-nine women who had received psychiatric treatment were drug
users. 
A more recent survey of male (n=1,148) and female prisoners (n=57) found that
women prisoners were more likely than their male counterparts to smoke heroin
and/or inject drugs (Allwright, Barry, Bradley, Long & Thornton, 1999).  Almost
three-fifths (59.6%) of the women surveyed, reported smoking heroin, compared
to 45.2 per cent of male respondents. Three-fifths (59.6%) of women also reported
ever injecting, compared to just over two-fifths (42.4%) of men. 
Summary
The results of two surveys of the prison population suggest that opiate use is a
serious problem among women in the Irish prison system.  Furthermore, women
in prison appear more likely than their male counterparts to smoke or inject
heroin (Allwright et al., 1999).
4.6 Pregnancy and Drug Use
Maternal drug addiction was first recognised as a problem in Ireland in 1981,
when nine babies were born to heroin-addicted mothers attending one of the
main maternity hospitals in Dublin (Ryan, Arthurs, Kelly & Fielding, 1982).  This
represented a marked increase, as the previous eight years (1973-1980) had seen
only a total of six babies born to heroin-addicted mothers. A socio-demographic
profile of thirteen of the fifteen opiate-addicted mothers indicated that the
majority (69%) were under 20 years of age, half were unemployed and only one
had completed post-primary education. All the women were heavy cigarette
smokers. One third of the women had a parent with a nervous or psychiatric
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history and less than a quarter described their relationship with their parents as
good. Furthermore, nine of the thirteen women had received treatment for
emotional or psychiatric disorders.  In terms of physical health, seven had
hepatitis and two had venereal diseases.  The profile of the partners of these
women indicates that twelve of the thirteen partners were drug addicts and only
two gave the mother any support or assistance when she was pregnant.
Although none of the infants were small for gestational age, anxiety about the
social conditions of mothers led to longer hospitalisation and separation of the
infants from their mothers. This study also investigated the short-term outcome
for the infants and their mothers.  The results indicated that two mothers were
drug free, two had developed serious neurotic illnesses following withdrawal,
one was hospitalised for a drug-related psychiatric illness, and the remainder
were still addicted. Furthermore, three of the babies had been taken into care.
A similar profile of the pregnant drug user emerges from a study of the
characteristics of thirty pregnant women who attended the National Drug
Advisory and Treatment Centre, Jervis Street, Dublin, between 1969 and 1983
(Kelly, Roche, Stafford-Johnson & Honeyman, 1983).  Interestingly, the age of
first contact for pregnant drug users was, on average, a year and a half younger
than non-pregnant women attending the same service.  The study found that the
majority (87%) of pregnant opiate users had left school before the age of 16.  A
third of the women were married and living with their husbands. The majority
(83%) of the women's partners misused drugs or alcohol and over a third (37%)
had a record of crime or violence. Only three of the women had partners who
gave them consistent support and assistance during their pregnancies. Almost
three-quarters (73.3%) of the women had a behavioural disorder or received
psychiatric treatment prior to drug taking. An investigation of the family
background of these women revealed that a quarter of the women had mothers
who had a psychiatric problem or were excessive drinkers. A third of the
women's fathers were excessive drinkers and a quarter were reported as being
violent or criminal.  On a more positive note, over half the women received on-
going support from their mothers, and almost half were described as having a
good relationship with their own family. Similar to the earlier study, babies born
to drug-addicted mothers were hospitalised for longer and therefore separated
from their mothers at an early age. The women appeared reluctant to avail of
healthcare services both prenatally and postnatally. Only half the women
attended for antenatal care at an early stage. Many of the mothers were resistant
to any health board involvement postnatally and many refused to attend for the
normal developmental checks and vaccinations.
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In terms of outcome, at least 65 per cent of the mothers were known to have
returned to serious drug misuse (21.5% lost contact with the Centre and their
outcome is unknown), and three (11%) remained drug free.  In the majority of
cases (70.3%), babies were in the care of their mother; in the remainder of cases,
babies were either in the care of a grandmother or jointly cared for by the
grandmother and the mother (11%), or had been adopted (11%).  In two cases,
the outcome was unknown. 
Another retrospective study, of twenty-nine narcotic-addicted mothers and their
forty-two babies born between 1982 and 1985, found that the average maternal
age was 23 and, in all cases where information was available (29 of 38
pregnancies), all fathers were drug users (Thornton, Clune, Maguire, Griffin &
O'Connor, 1990).  Twenty-three of the twenty-nine mothers (79%) were on a
methadone maintenance programme during pregnancy, but they all continued
to use heroin intermittently. All the women were from socially-deprived areas
and all, except one, smoked cigarettes.  In terms of physical health, four of the
mothers had a hepatitis B infection and thirteen had a previous history of
hepatitis B infection. In comparison to a matched control group, babies born to
heroin-using mothers had significantly lower birth weights and mean
gestational periods and were more likely to develop jaundice. In addition,
heroin-using mothers made fewer antenatal visits and were admitted to hospital
more often and for longer stays than were the control group.  A high incidence
of withdrawal symptoms was recorded, with 84 per cent of babies suffering
some symptoms of withdrawal.  The incidence of multiple births (i.e. twins) was
also much higher among drug-using mothers (10.5%) compared to the control
group (1.2%).  
Another similar study, conducted in 1988, examined the characteristics and
treatment progress of forty-five opiate addicts referred to a treatment centre
between 1984 and 1986 (O'Connor, Stafford-Johnson & Kelly, 1988).  The psycho-
social profile of this group indicates that all were unemployed, were regular
smokers and had left school on average at the age of 14.  The average age of first
use of heroin was 16.5 years and the average age at the time of the study was 23.3
years.  Almost half (46.6%) of the women had used heroin intravenously as their
first illicit drug. The average length of time on drugs before referral was three
years. Interestingly, the majority of mothers (86.7%) were attending the clinic for
an average of 2.5 years before becoming pregnant.  Four-fifths were single.
Almost all (95.5%) had been convicted of a criminal offence.  In terms of family
profiles, nearly half the women had fathers who suffered from alcoholism and a
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third had mothers who suffered from alcoholism or depression.  Over half
(55.5%) reported severe family disharmony. This study also investigated HIV
status and found that fifteen of the forty-five women were HIV positive. Over
half the women had a history of hepatitis B infection. Almost half (45%) the
women responded positively to treatment during pregnancy, as indicated by
regular attendance, non-abuse of drugs (as detected through the results of
supervised urinalysis), discontinuation of criminal behaviour and improved
awareness of their children's needs (O'Connor et al., 1988). 
A six-year follow-up of these women was conducted, focusing on their drug use
and the outcome for their children (Keenan, Dorman & O'Connor, 1993).  On
follow-up, seven of the forty-five women (15%) could not be contacted.  Of the
remaining thirty-eight, ten were on methadone maintenance, eighteen were
either attending another service or abusing chaotically, three had become drug
free and seven had died from drug-related illnesses. Of the women who had
died, four had died from AIDS and three from drug overdoses, two of which
were accidental and one deliberate. Over the six-year period, all but two of the
women (4.5%) had re-attended at the treatment centre at least once, and twenty-
five women (55.6%) had attended at least four times.   There was an increase in
the number of women with HIV, from one-third of the group to over half the
group (53.4%) during the six years (1986-1992), and a quarter of the fifteen
children born to HIV-positive mothers before 1996 had become HIV positive.
More worrying was the fact that fourteen of the eighteen HIV-positive women,
who were still alive, were not attending any medical service on a regular basis.
This may be, in part at least, related to a fear of being seen as an unfit mother, a
reason cited earlier among HIV-positive women for not accessing services
(Butler & Woods, 1992). The increase in the incidence of HIV among the women
is interpreted by the authors as signifying instability and poor compliance with
advice and treatment. On a more positive note, since 1986 only three of the
women (6.6%) had contracted hepatitis B infections, compared to twenty women
(45%) prior to 1986. Over half the women (55.5%) had no further children and
there was also a decrease in the level of criminal activity among the women.
Before 1986, nearly all the women (97.8%) had a forensic history.  However, since
1986 just over half the women had been in contact with the criminal justice
system.
All the studies discussed so far have specifically focused on opiate-using
mothers. A more recent study has examined the prevalence of drug and alcohol
use in an obstetric population in the Dublin area (Bosio et al., 1997). This
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prospective study involved anonymous urinalysis of 504 'first-visit' antenatal
patients and 515 postnatal patients six weeks after delivery. The study found
that the prevalence rate for drug use in antenatal patients was 2.8 per cent; the
corresponding postnatal figure was 5.6 per cent. Cannabis was found to be the
most commonly-misused substance. Women who tested positive for drugs
antenatally were almost twice as likely to be single, unemployed and on a second
or subsequent pregnancy. The higher postnatal rate of drug use is interpreted as
possibly indicating a more responsible pattern of behaviour during pregnancy,
in an effort to minimise exposure of the foetus to chemical substances. Bosio et
al. (1997) conclude that drug abuse does not appear to be a serious problem
among Dublin's pregnant population. However, they acknowledge that drug
users may present late in pregnancy, as has been found in previous studies of
pregnant opiate users (Kelly et al., 1983; Thornton et al., 1990). 
Summary
The research available on opiate addiction and pregnancy in Ireland suggests
that opiate-dependent pregnant women are a high-risk medical category, with
many psychological and social problems.  Numerous studies have shown that
opiate-using pregnant women tend to be young, poorly educated, regular
tobacco smokers, and from socially-deprived areas.  Research also indicates that
these women tend to be involved with a partner who also misuses drugs and to
have poor family relationships, or come from families with a history of alcohol
misuse, drug abuse and/or psychological problems. The level of psychological
difficulties among the families of these women is consistent with findings
internationally that dysfunctional family life, rather than poverty, seems to be
one of the most significant predisposing factors to drug use (United Nations
Drug Control Programme, 1997).
4.7  Children and Drug Use 
In Ireland, the issue of how children are affected by parental drug dependence is
emerging as a new social and clinical concern (Hogan, 1998). In an exploratory
study, Hogan had noted that little is known about the social and psychological
effects on children of parental drug use: 'the main focus of existing research in
Ireland has been on prenatal chemical exposure of children to drugs rather than
on postnatal social exposure' (Hogan, 1997: 4). 
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Although the prevalence of parenthood among drug users is unknown, the fact
that the majority of treated drug abusers in Ireland are of child-bearing years
(Moran et al., 1997), coupled with anecdotal evidence that many drug users are
parents, suggests that a large number of children may be affected by drug abuse.
The statistics for treated drug misuse indicate that, in 1998, 9 per cent of women
presenting for treatment stated, when asked about their living status, that they
were lone parents (NDTRS)3.  However, the NDTRS does not capture parental
status per se and the number of drug-using women who have children is likely
to be much higher. A study of the parental status of clients attending a voluntary
drug agency (Ana Liffey Project) found that over three-quarters of the 186
women attending the service during 1992 were parents (Woods, 1994). Over
three-fifths (62.8%) of the 142 mothers were caring for their own children.   A
possible explanation for the high level of attendance of mothers at the voluntary
agency may be that voluntary services are perceived as less threatening than
statutory services among drug-using women with children (Woods, 1994).   It is
likely that some women with children may be reluctant to approach treatment
services because of concerns about being seen as an 'unfit mother' (Butler &
Woods, 1992). 
One of the earliest references to children and drug misuse, in the Irish context, is
a case study of a boy who had begun misusing drugs before his eleventh
birthday (Ryan et al., 1982).  The boy, who was 12 years old on admission to the
Drug Advisory and Treatment Centre, had been abusing a number of drugs
including diconal, palfium, cocaine and heroin for eighteen months. At this time,
it was discovered the boy had chronic hepatitis B infection with cirrhosis. The
boy was from a large family (he was third eldest in a family of ten), his father
was unemployed and his mother suffered from a neurotic disorder with
agoraphobic symptoms.   He was also on probation, having broken into a car. He
had been attending a special school for two years and had presented with
behavioural problems at 7 years of age. Ryan et al. (1982) comment on the
difficulties encountered in the hospitalisation and placement of very young
offenders with drug problems, as exemplified by this case.
Another study, which is relevant in this context, although it does not focus on
children per se, is a study that looked at the risks associated with methadone
storage. Following a coroner's hearing into the death of a 3-year-old boy, who
died after ingesting methadone stored in a baby's feeding bottle, a study was
conducted to investigate the extent to which babies' bottles were used to
m e a s u r e
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3 National Drug Treatment Reporting System 
and store methadone (Harkin, Quinn & Bradley, 1999).  The study involved nine
general practitioners, who asked 186 patients in receipt of a methadone
prescription whether or not they used a baby's bottle to measure methadone, and
if they had children under the age of 14.  The results indicated that almost a
quarter of patients (n=48) had used a baby's bottle to measure methadone in the
previous month, and twenty-one (43%) of these had a child under the age of 14.
Furthermore, seven patients had used a baby's bottle to store methadone in the
previous month, and four of these had a child under the age of 14. Although it is
difficult to draw conclusions from these findings, they suggest that the use of a
baby’s bottle to measure and/or store methadone may present a threat to the
health of children  
In an attempt to redress the lack of research on children of drug users in Ireland,
Hogan (1997) is conducting a two-stage study on the social and psychological
effects on young children of parental heroin use. The first part of the study,
which involved a qualitative study of ten families, in which one or both parents
were opiate users, has been completed. Interviews were conducted with thirty
informants consisting of parents, teachers, professional workers and non-
parental caregivers. The study found that all the children (n=10) in the sample
had at least one parent who had been incarcerated and that the majority had
experienced separation from their parents owing to parental drug use (Hogan,
1997).  From the interviews with teachers and parents, it emerged that only a few
children showed evidence of social-emotional problems; however, the majority
were experiencing difficulties at school.  Parents expressed three main concerns
about how their drug use might impact adversely on their parenting.  The first
concern related to their pre-occupation with obtaining drugs, which might result
in inadequate attention being paid to their children. The second worry was that
their drug use would affect their social interaction with their children. The third
related to a prevailing atmosphere of secrecy in the home owing to parental drug
use and the possible development of distrustful relationships between the
parents and children. Key workers interviewed were particularly concerned
about the questionable quality and consistency of care-giving by drug-using
parents, the danger of physical neglect, and the possibility that children might
witness drug use. Interestingly, all these concerns were raised in a recent
editorial in the journal Addiction (Barnard, 1999).  Key workers also emphasised
that there were a number of parents about whom no concerns existed and whose
competence they stressed. Thus, as Barnard (1999) points out, it cannot be
assumed that drug dependence automatically results in diminished capacity to
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parent adequately or that the development of children is necessarily adversely
affected by parental drug use.
Hogan (1997) also identifies a number of variables that mediate the effects on
children of parental drug use, including the living arrangements of the child, the
social support available to parents, the extent to which one or both parents are
in treatment, whether or not the drug-using parent is in treatment, the history of
drug use and treatment, the age of the child when parents begin using heroin
and whether or not this drug use is chaotic.  Stage 2 of Hogan's study, which is
currently under way, investigates the extent to which children are exposed to the
drug culture and aims to examine the consistency and adequacy of care
provided to children of drug users.
Summary
Although the extent to which children in Ireland are affected by drug misuse is
unknown, a study of drug-using women attending a voluntary agency suggests
that many drug-using women are also parents (Woods, 1994). Very little is
known about the needs of children of drug users in Ireland; however, a study is
under way that aims to investigate the needs of drug users and their children
(Hogan, 1997). The first phase of this study has been completed and has found
that the majority of children experienced separation from one or both of their
parents owing to drug use.  Parents, key workers and teachers interviewed
expressed concerns about the possible impact of drug use on children. The study
also identifies a number of variables such as the social support available to
children and drug-using parents that can influence the extent to which parental
drug use affects children.
4.8 Demand Reduction (Prevention, Treatment and Care) 
and Female Drug Users
A small number of initiatives have been developed specifically for women in
Ireland.  The focus of these initiatives has been on treatment, rehabilitation and
care rather than prevention. There is at least one harm-reduction programme in
place especially for women.
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Harm Reduction
A harm-reduction programme for women sex workers who are using drugs has
been set up by the Merchant's Quay Project, a voluntary organisation providing
services to drug users and persons with HIV/AIDS in Dublin's city centre
(Merchant's Quay Project, 1998).  The harm-reduction programme is overseen by
a healthcare worker and operates on a weekly basis, offering services such as
needle exchange and condom distribution. The programme has produced some
positive outcomes, with some clients subsequently progressing to the Mobile
Clinic (a low-threshold service) and to detoxification programmes.  
Treatment
Some treatment facilities in Ireland have support groups or drop-in times
designated for women only (e.g. Ana Liffey Project).  One service, the Merchant's
Quay Project, accommodates mothers wishing to access the needle exchange,  by
allocating hours in the morning, found to be more suitable for women with
children.  However, there are very few treatment services dedicated to providing
programmes specifically for women drug users.  The treatment services
available in Ireland specifically for women drug users include a drug-free
residential programme, and services developed for pregnant women.
The Coolmine Therapeutic Community provides a residential drug-free
programme specifically for women at Ashleigh House, Clonee, County Meath.
This programme, based on the Minnesota Model,4 involves an abstinence-
orientated approach. At the time of writing there were twenty-five women
participating in this programme. Ashleigh House is currently being renovated to
accommodate mothers and their children, as part of a project funded through a
Local Drug Task Force.  When completed, the facility will allow five to ten
mothers, with up to two children each, to participate in the programme.
A special programme for pregnant opiate addicts in Ireland was established by
the then National Drug Advisory and Treatment Centre  in 1984, in response to
the growing numbers of pregnant clients attending the clinic (O'Connor et al.,
1988). The programme involved low-dose methadone maintenance, weekly
group therapy and fortnightly attendance at antenatal clinics (Keenan et al.,
1993). Participants in the programme were also encouraged to attend 
4 Associated with the Alcoholics/Narcotics Anonymous programmes, the Minnesota model offers a 12
step programme to long term abstinence based on the idea that addiction is a disease. Devised by the
Hazelden Hospital in Minnesota, the programme offers spiritual as well as practical guidance.
(www.drugscope.org.uk)
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programmes outside the clinic where appropriate.  Postnatally, women were
given advice about contraception and encouraged to address their addiction.
Participation in the programme was conditional on non-consumption of drugs,
as monitored by daily, supervised urinalysis, engagement in weekly group
meetings, and attendance at antenatal care. 
According to Williams & Kinsella (1990), other services available to pregnant
opiate addicts in Ireland include group therapy, occupational therapy,
individual counselling and support groups for family members. In Ireland,
methadone maintenance is generally the preferred treatment option for pregnant
opiate users for a number of reasons.  Firstly, it is hoped that the prescription of
methadone will reduce/eliminate illicit opiate misuse during pregnancy.
Secondly, the administration of regulated methadone doses helps to reduce the
risk of an infant developing withdrawal symptoms in the immediate postnatal
period (Keenan et al., 1993).  Thirdly, methadone maintenance encourages better
antenatal care and a more stable drug environment for mother and child (Kelly
et al., 1983). 
The Eastern Health Board (EHB)  employs three drug liaison midwives to make
contact with substance-misusing pregnant women and to liaise between the
obstetric hospitals and the drug-treatment services. The midwives are
responsible for ensuring that the medical, psychological, obstetrical and social
needs of each woman have been accurately assessed and for drawing up a
detailed clinical/psychological/social care plan for each woman (Eastern Health
Board, 1998). 
A unit, which will provide intensive medical care to stabilise expectant drug-
addicted mothers and improve neonatal outcome, is currently being planned
and will be located in Dublin's Cherry Orchard Hospital (Vize, 1999).  The
twelve-bed facility will offer intensive medical treatment by a psychiatrist with
a team of specially-trained nurses, and access to counselling and screening.
Additionally, the unit will incorporate a facility for female addicts who have
delivered and since destabilised, which will allow mother and baby to remain
together while treatment is being administered.  At present, only three of
seventeen beds in the detoxification unit of the hospital are allocated to pregnant
women requiring stabilisation. According to Dr Keenan, consultant psychiatrist
in the EHB, the new unit should have a significant impact on the prevalence of
neonatal complications and morbidity associated with opiate dependent
pregnancies (Vize, 1999). 
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Care and Rehabilitation
At the time of writing, the most recent service plan for the largest health board
area in Ireland (Eastern Health Board) has placed an increased emphasis on
after-care and rehabilitation.  Although there is no particular emphasis on
women-only services, SAOL has been established, providing rehabilitation and
support for women who are stable opiate users.  SAOL stands for Seasamhacht,
Abaltacht, Obair, Leann, meaning stability, ability, work and learning - the word
'saol' means life. The project, which began in 1995 in Dublin's north inner city,
offers a two-year programme for sixteen women.  The project aims to help clients
move from addiction and dependency to self-direction and self-reliance. The
programme incorporates a wide variety of activities, including literacy skills,
English, creative writing, aromatherapy, relaxation and massage. It is based on
the principles of social justice, equality and inclusion. A review of the
programme by Weaver (1998) indicates that participants view the programme as
a 'job', which gives them a perceived status in the community.  Participants
reported increased levels of self-esteem, ability to re-establish relationships with
family members and becoming reintegrated into their communities as a result of
the programme.
Summary
Very few services have been developed specifically for women.  Some treatment
centres accommodate women and children by having more flexible opening
hours for this client group. There is one residential drug-free programme for
women only.  Services have also been developed for pregnant opiate users and
a harm-reduction programme is in place in the Dublin area.  A women-only
rehabilitation service has also been established.  
4.9  Barriers to Service Access
In examining the services available to female drug users and their children, it is
also important to examine possible barriers, which would prevent or inhibit
women from accessing services.
A recent Dublin study found that lack of childcare facilities is a barrier to
accessing drug treatment, in particular for women (Moran, 1999).  The research
found that only nine of forty-five drug-treatment centres in Dublin provided
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crèche facilities.  Interviews were conducted with a wide variety of personnel
(including crèche leaders and workers, treatment staff, parents/guardians, and
children attending the crèche) in six of the nine centres offering crèche facilities.
The results indicate that crèches are perceived as playing an important role in the
children's emotional, psychological and educational development. It was also
found that crèche leaders facilitate mothers in their parenting by providing
advice and help in relation to parenting skills. Furthermore, having access to a
crèche influences parents' willingness to attend treatment and their
psychological approach to treatment.
Butler & Woods (1992) found that HIV-positive female drug users were less
likely to seek treatment, owing, in part at least, to fears of being judged an unfit
parent and having their children taken into care by the State. Similarly, Hogan
(1997), in her study of the psychological and social needs of the children of drug
users, found that mothers' fears of having their children taken into care were
quite pronounced. 
Dunne (1994), in a study exploring the service needs of fifty female drug addicts,
found that the vast majority (82.5%) had family support, mainly from their
mothers. Consistent with other studies, the majority (71%) had drug-using
partners. More worrying was the finding that half the women had partners who
were described as violent. When asked what services were important to them,
'women-only support groups' were most frequently mentioned, followed by
welfare, one-to-one counselling, crèche facilities, relaxation and parenting skills.
The study concludes by recommending that female support groups with
professional facilitation be established in each treatment centre and that crèche
facilities be extended and improved in drug-treatment facilities. 
Summary
Lack of crèche facilities and fears of being seen as an 'unfit mother' appear to be
the main barriers facing Irish drug-using women seeking treatment.  An analysis
of the needs of drug-using women also suggests that female support groups are
considered an important aspect of treatment. 
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4.10  Conclusion
It is apparent that research on women, children and drugs in Ireland has focused
almost exclusively on pregnant opiate addicts.  Consequently, there is a lack of
information on how drug use affects women in general and how parental drug
use impacts on children.  
The available research suggests that Irish female drug users engage in more risk
behaviour than their male counterparts, which has significant health
implications, increasing their likelihood of contracting HIV and hepatitis B and
C infections.  The profile of the pregnant opiate user clearly indicates that these
women are in need of a very high level of support. The high rate of drug use
among women prisoners is also an issue of concern. 
Lack of crèche facilities and fears of being seen as an 'unfit mother' appear to be
two of the main barriers preventing women from accessing treatment.
Consequently, an increase in the provision of crèche facilities would help more
women gain access to services.  Similarly, it appears that assurances need to be
given to female drug users seeking treatment, that accessing services will not
jeopardise their custody of their children. 
The available indicators all suggest that female drug users have particular needs
that require to be taken into account in service planning and provision. Much
more research effort is needed into the issues surrounding drug use by women
in Ireland and internationally.
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